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Whole blood cell parameters help us predict  
the prognosis in patients with acute ST segment  
elevation myocardial infarction: Myth or reality?
We have read the recently published article 
by Çiçek et al. “White blood cell count to mean 
platelet volume ratio: A novel and promising 
prognostic marker for ST-segment elevation myo-
cardial infarction” with great interest [1]. In that 
well-designed article, the authors aimed to evalu-
ate the predictive value of admission white blood 
cell count (WBC) to mean platelet volume (MPV) 
ratio (WMR) on prognosis in 2,603 consecutive 
patients with ST elevation myocardial infarction 
(STEMI), undergoing primary percutaneous coro-
nary intervention (pPCI). They found that WMR 
has the highest area under receiver operating char-
acteristic (ROC) curve, and pairwise comparisons 
of the ROC curves revealed that WMR has higher 
discriminative ability for long-term mortality than 
WBC, MPV, red blood cell distribution with (RDW), 
WBC-MPV combination, and platelet to lympho-
cyte ratio and neutrophil to lymphocyte ratio (PLR-
-NLR) combination in patients undergoing pPCI for 
STEMI. They concluded that higher WMR value on 
admission was associated with worse outcomes in 
patients with STEMI and independently predicted 
the long-term mortality better than other complete 
blood count components, such as MPV, RDW, and 
PLR-NLR and WBC-MPV combinations.
The ‘no-reflow’ phenomenon in patients with 
STEMI is associated with worse prognosis at 
short- and long-term follow-up periods [2, 3]. 
The mechanisms responsible for the ‘no-reflow’ 
phenomenon have not been clearly understood 
yet. Pathophysiology of ‘no-reflow’ phenomenon 
comprises reperfusion injury, distal atherothrom-
botic embolization, ischemic injury, and increased 
susceptibility of coronary microcirculation to 
injury [2].
Automated blood cell counters are commonly 
available in clinical laboratories and they can be 
used to determine RDW, platecrit, platelet count, 
platelet distribution width (PDW), MPV and some 
ratios, e.g. neutrophil-lymphocyte ratio (NLR), 
RDW-platelet ratio (RPR), PLR-NLR and WBC- 
-MPV ratios. It was shown that some hematologic 
parameters such as MPV, RDW, NLR and PLR 
may play a role in predicting worse outcomes in 
patients with STEMI undergoing pPCI [4–6]. Our 
group previously found that admission PDW and 
MPV are independent correlates of ‘no-reflow’ and 
in-hospital major adverse cardiac events (MACEs) 
among patients with STEMI undergoing pPCI [7]. 
Moreover, we also showed that female gender, pain 
to balloon time, high Thrombolysis in Myocardial 
Infarction (TIMI) thrombus grade, tirofiban, MPV, 
and PLR were independent predictors of ‘no-
-reflow’ in young patients with STEMI after pPCI 
[8]. What is more, we tried to evaluate the relations 
between pre-procedural RPR and the in-hospital 
and long-term outcomes in 580 STEMI patients 
undergoing pPCI [9]. In that study, pain to balloon 
time, multivessel disease, TIMI thrombus grade, 
tirofiban, aspirin, previous coronary artery disease, 
NLR, platecrit, and RPR remained independent 
predictors of ‘no-reflow’ after pPCI on multivari-
ate analysis. Patients in ‘no-reflow’ group tended 
to constitute a higher percentage of in-hospital 
MACE, including nonfatal myocardial infarction 
and cardiovascular mortality compared to the re-
flow patients. We concluded that admission NLR, 
platecrit, and RPR are independent correlates of 
‘no-reflow’ and in-hospital MACEs among patients 
with STEMI undergoing pPCI.
In summary, admission complete blood cell 
parameters are easily obtained bedside for the pre-
diction of short- and long-term mortality in patients 
with STEMI undergoing pPCI. From that point of 
view we strongly believe that further large-scale 
prospective trials are urgently needed to clarify 
the exact role of complete blood cell parameters 
in predicting short- and long-term mortalities in 
that patient setting.
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